Duchenne Muscular Dystrophy
FY25 Clinical/Translational Research Award - Funding Level 2
The list of Fiscal Year 2025 Duchenne Muscular Dystrophy Research Program Clinical/Translational Research Award - Funding Level 2 applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| Ikaika Therapeutics Inc | Dimitra Georganopoulou |
| The Children's Hospital of Philadelphia | Lindsey George |
| University of California, Los Angeles | Melissa Spencer |
Last updated Wednesday, March 18, 2026